ATE291431T1 - Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren - Google Patents
Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumorenInfo
- Publication number
- ATE291431T1 ATE291431T1 AT97947157T AT97947157T ATE291431T1 AT E291431 T1 ATE291431 T1 AT E291431T1 AT 97947157 T AT97947157 T AT 97947157T AT 97947157 T AT97947157 T AT 97947157T AT E291431 T1 ATE291431 T1 AT E291431T1
- Authority
- AT
- Austria
- Prior art keywords
- dextrine
- treat
- sulfate
- vascular tumors
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Compounds Of Unknown Constitution (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9625193.9A GB9625193D0 (en) | 1996-12-04 | 1996-12-04 | Treatment of highly vascular tumours |
| PCT/GB1997/003315 WO1998024421A2 (en) | 1996-12-04 | 1997-12-01 | Use of dextrin sulphate for the treatment of highly vascular tumours |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE291431T1 true ATE291431T1 (de) | 2005-04-15 |
Family
ID=10803921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97947157T ATE291431T1 (de) | 1996-12-04 | 1997-12-01 | Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6297225B1 (de) |
| EP (1) | EP0938323B1 (de) |
| JP (1) | JP2001505572A (de) |
| CN (1) | CN1239430A (de) |
| AT (1) | ATE291431T1 (de) |
| AU (1) | AU724501B2 (de) |
| BR (1) | BR9713828A (de) |
| CA (1) | CA2273846A1 (de) |
| DE (1) | DE69732851D1 (de) |
| GB (1) | GB9625193D0 (de) |
| WO (1) | WO1998024421A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9917092D0 (en) * | 1999-07-22 | 1999-09-22 | Ml Lab Plc | Treatment of angiogenesis-dependent conditions |
| GB0102559D0 (en) * | 2001-02-01 | 2001-03-21 | Ml Lab Plc | Treatment for angiogenesis-dependant condition |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK505488D0 (da) | 1987-12-21 | 1988-09-09 | Bar Shalom Daniel | Middel og anvendelse af samme |
| GR1000597B (el) * | 1988-01-19 | 1992-08-26 | Judah Moses Folkman | Παραγοντας αναστολης αναπτυξης και χρηση του. |
| GB9020861D0 (en) * | 1990-09-25 | 1990-11-07 | Ml Lab Plc | Pharmaceutical compositions |
| WO1993012808A1 (en) * | 1991-12-20 | 1993-07-08 | Shuji Nakamura | A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| US5783568A (en) | 1994-06-10 | 1998-07-21 | Sugen, Inc. | Methods for treating cancer and other cell proliferative diseases |
-
1996
- 1996-12-04 GB GBGB9625193.9A patent/GB9625193D0/en active Pending
-
1997
- 1997-12-01 WO PCT/GB1997/003315 patent/WO1998024421A2/en active IP Right Grant
- 1997-12-01 AU AU52307/98A patent/AU724501B2/en not_active Ceased
- 1997-12-01 BR BR9713828-2A patent/BR9713828A/pt not_active IP Right Cessation
- 1997-12-01 AT AT97947157T patent/ATE291431T1/de not_active IP Right Cessation
- 1997-12-01 CN CN97180287A patent/CN1239430A/zh active Pending
- 1997-12-01 EP EP97947157A patent/EP0938323B1/de not_active Expired - Lifetime
- 1997-12-01 US US09/319,483 patent/US6297225B1/en not_active Expired - Fee Related
- 1997-12-01 CA CA002273846A patent/CA2273846A1/en not_active Abandoned
- 1997-12-01 DE DE69732851T patent/DE69732851D1/de not_active Expired - Lifetime
- 1997-12-01 JP JP52533898A patent/JP2001505572A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU5230798A (en) | 1998-06-29 |
| JP2001505572A (ja) | 2001-04-24 |
| BR9713828A (pt) | 2000-03-14 |
| WO1998024421A3 (en) | 1998-10-15 |
| EP0938323B1 (de) | 2005-03-23 |
| GB9625193D0 (en) | 1997-01-22 |
| WO1998024421A2 (en) | 1998-06-11 |
| CN1239430A (zh) | 1999-12-22 |
| US6297225B1 (en) | 2001-10-02 |
| CA2273846A1 (en) | 1998-06-11 |
| EP0938323A2 (de) | 1999-09-01 |
| AU724501B2 (en) | 2000-09-21 |
| DE69732851D1 (de) | 2005-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE300292T1 (de) | Thyroxin-analoge mit keiner signifikanten hormonellen aktivität zur behandlung von bösartigen tumoren | |
| ATE230605T1 (de) | Wundheilmittel und behandlung von fibrotischen storungen durch tgfbeta-3 | |
| ATE258796T1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
| ATE282425T1 (de) | Verfahren zur behandlung von endothelialen verletzungen | |
| ATE395928T1 (de) | Expressionsvektoren und zellinien zur expression von vaskulärem wachstumsfaktor d, sowie verfahren zur behandlung von melanomen | |
| DE69807349D1 (de) | Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren | |
| ATE411016T1 (de) | Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten | |
| DE69403969D1 (de) | Levobupivacain nützlich zur behandlung von chronischen schmerzen | |
| DE69526937T2 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
| ATE198706T1 (de) | Polyamin-verbindungen zur behandlung von proliferativer erkrankungen | |
| BR9407824A (pt) | Processos para tratar e para interromper e reverter alopécia androgência e para diminuir o nível de 5 &-di-hidro-testosterona no escalpo humano | |
| DE68917433T2 (de) | Verfahren zur behandlung von asbest sowie asbestbehandlungsmittel. | |
| DE69229780T2 (de) | Zusammensetzung und methode zur behandlung von störungen in form von depigmentierung | |
| DE69304843D1 (de) | Methode zur Behandlung von Haarausfall | |
| ATE291431T1 (de) | Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren | |
| DE69818809D1 (de) | Verfahren zur behandlung von narbengewebe | |
| ATE294582T1 (de) | Verwendung von alpha-1-adrenorezeptor- antagonisten zur herstellung eines medikaments für die vorbeugung und die behandlung von krebs | |
| DE69218200D1 (de) | Behandlung von leberkrebs | |
| DE69720064D1 (de) | Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen | |
| DE69833727D1 (de) | Verfahren zur Behandlung der Gefässerkrankungen mit aktiviertem Protein C | |
| DE69124382T3 (de) | Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände | |
| DE68909750T2 (de) | Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias. | |
| DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| ATE178336T1 (de) | Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis | |
| DE69430807T2 (de) | Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |